Cargando...
Pharmacokinetics and Safety of Moxifloxacin in Children With Multidrug-Resistant Tuberculosis
Background. Moxifloxacin is currently recommended at a dose of 7.5–10 mg/kg for children with multidrug-resistant (MDR) tuberculosis, but pharmacokinetic and long-term safety data of moxifloxacin in children with tuberculosis are lacking. An area under the curve (AUC) of 40–60 µg × h/mL following an...
Gardado en:
| Publicado en: | Clin Infect Dis |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4366580/ https://ncbi.nlm.nih.gov/pubmed/25362206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciu868 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|